Tag: Medicines and Healthcare products Regulatory Agency
MHRA strengthens restrictions on fluoroquinolone antibiotics
Patients are advised to discontinue use of fluoroquinolones at the first signs of a serious adverse reaction
Britain's drug regulator, the Medicines and Healthcare...
WHO prequalifies nOPV2 polio vaccine co-developed by MHRA scientists
This makes it easier for more countries to obtain and use the vaccine to protect children from the disabling and life-threatening disease
The Medicines and...
UK approves Mirena levonorgestrel IUS for extended use up to 8 years for contraception
The extended use of Mirena in contraception will not only reduce the number of IUS removal and insertion procedures, but also the potential risk...
MHRA’s new IRP goes live, developers of new medicines can now submit applications
The EC Decision Reliance Procedure (ECDRP) has been replaced by the new International Recognition procedure (IRP)Â
The Medicines and Healthcare products Regulatory Agency (MHRA) made...
MHRA approves Bristol Myers Squibb’s Opdualag for advanced melanoma treatment
The American biopharmaceutical company receives marketing authorisation for the drug through Project Orbis
 The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved...
5 top tips from MHRA to stay safe during the festive season
Some food and drinks that are often associated with Christmas may interact with your medicine and increase risk of experiencing side effects
The Medicines...